Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Low-density lipoprotein Stories

2014-01-30 16:26:43

RUTHERFORD-2 Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction THOUSAND OAKS, Calif., Jan. 30, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 RUTHERFORD-2 (RedUction of LDL-C with PCSK9 InhibiTion in HEteRozygous Familial HyperchOlesteRolemia Disorder Study-2) trial evaluating evolocumab in combination with statins and other lipid-lowering therapies in patients with heterozygous familial hypercholesterolemia (HeFH) met its co-primary...

2014-01-29 12:27:52

WOODBRIDGE, ON, Jan. 29, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies, announced that it received a Notice of Allowance for U.S. Application Serial Number US2012/025014 from the United States Patent and Trademark Office (USPTO). The patent titled "Formulations Comprising Omega-3 Fatty Acids and Anti-Obesity Agent for the Reduction of Body Weight in Cardiovascular Disease Patients (CVD)...

2014-01-28 16:26:04

Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction THOUSAND OAKS, Calif., Jan. 28, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 LAPLACE-2 (LDL-C Assessment with PCSK9 MonoclonaL Antibody Inhibition Combined with Statin ThErapy-2) trial evaluating evolocumab in combination with statin therapy in patients with high cholesterol met its co-primary endpoints: the percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at week...

2014-01-23 08:31:51

Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction THOUSAND OAKS, Calif., Jan. 23, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 GAUSS-2 (Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-2) trial evaluating evolocumab in patients with high cholesterol who cannot tolerate statins met its co-primary endpoints: the percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at week 12 and the...

2014-01-22 10:31:44

Icahn School of Medicine at Mount Sinai designs HDL nanoparticle to deliver statin medication inside inflamed blood vessels to prevent repeat heart attacks and stroke Up to 30 percent of heart attack patients suffer a new heart attack because cardiologists are unable to control inflammation inside heart arteries — the process that leads to clots rupturing and causing myocardial infarction or stroke. But a report in Nature Communications by Icahn School of Medicine at Mount Sinai...

2014-01-22 08:29:20

Sterol/Stanol Softgels Offer a Convenient Way to Improve Cholesterol Levels NORTHRIDGE, Calif., Jan. 22, 2014 /PRNewswire/ -- A research study published this month in the Journal of the Academy of Nutrition and Dietetics demonstrates the effectiveness of a sterol/stanol ester softgel capsule for lowering low-density lipoprotein (LDL) cholesterol in individuals with high cholesterol levels. Plant sterols and stanols occur naturally in plant-based foods and have been shown to decrease...

2014-01-20 23:03:55

Icahn School of Medicine at Mount Sinai Designs HDL Nanoparticle to Deliver Statin Medication Inside Inflamed Blood Vessels to Prevent Repeat Heart Attacks and Stroke New York, NY (PRWEB) January 20, 2014 Up to 30 percent of heart attack patients suffer a new heart attack because cardiologists are unable to control inflammation inside heart arteries — the process that leads to clots rupturing and causing myocardial infarction or stroke. But a report in Nature Communications by Icahn...

Cholesterol To Treat Alzheimers
2013-12-31 13:46:58

Lee Rannals for redOrbit.com - Your Universe Online Researchers writing in the online journal JAMA Neurology said they found a new approach to lowering the prevalence of Alzheimer’s disease. University of California (UC), Davis researchers discovered that high levels of 'good' cholesterol and low levels of 'bad' cholesterol are correlated with lower levels of amyloid plaque disposition in the brain, which is an indicator of Alzheimer’s disease. “Our study shows that both higher...

2013-12-25 23:00:07

Crunch Cholesterol designed by Colin Carmichael is the latest program that helps people control their hypercholesterolemia naturally without any medication. Is Crunch Cholesterol review trustworthy? Seattle, Wa (PRWEB) December 25, 2013 Cholesterol is a waxy substance that is found in the fats or lipids in people’s blood. The body needs cholesterol to continue building healthy cells; however, having high cholesterol (hypercholesterolemia) can increase the risk of heart disease. Crunch...

2013-12-23 23:22:37

The new “Foods To Reduce Cholesterol” article written by Peter Schiff on the website Healthreviewcenter.com teaches people how to balance cholesterol level naturally. Seattle, Wa (PRWEB) December 23, 2013 The brand new ”Foods To Reduce Cholesterol” article penned by Peter Schiff on the website Healthreviewcenter.com delivers to people nutrition advice to decrease cholesterol level safely. This report is specifically designed for those men and women who want to keep their...